Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
OwnerIvan Bergsteininventor
Life of this patent
Estimating the term…
Abstract
Improved methods for treatment of cancer which involve the targeting of slow-growing, relatively mutationally-spared cancer stem line are provided. These methods are an improvement over previous cancer therapeutic methods because they provide for very early cancer treatment and reduce the likelihood of clinical relapse after treatment.
Claims30
An improved method of treating cancer which involves the administration of a therapeutic agent which selectively kills, inhibits or modulates the growth of cancer cells wherein the improvement comprises administering a therapeutic agent which provides for the selective killing, inhibition or modulation of the growth of a cancer stem line (defined as symmetrically dividing stem cells) present within a cancerous tumor.
A method of treating cancer which involves the administration of a therapeutic agent which selectively causes a cancer stem line to switch from symmetric mitosis to asymmetric mitosis.
A method of treating cancer which comprises the administration of at least one therapeutic agent which selectively cause a cancer stem line to switch from symmetric mitosis to symmetric differentiation thereby resulting in irreversible eradication or said cancer stem line.
Dependencies are inferred from the claim text.